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Based on clinical and radiological ﬁndings, Cottin deﬁned combined pulmonary ﬁbrosis and emphysema (CPFE) as pulmonary
emphysemaintheupperlungsandinterstitialpneumoniainthelowerlungswithvariousradiologicalpatterns.Pathologicﬁndings
of CPFE probably corresponded with diﬀuse interstitial pneumonia with pulmonary emphysema, emphysema with ﬁbrosis, and
the combination of both. We described reported radiological ﬁndings of CPFE.
1.Introduction
Interstitial pneumonia (IP) with pulmonary emphysema has
long been a topic of controversy because we have not decided
if the disease is simple coincidence of IP and emphysema or
IP and emphysema may be caused by common etiology. In
1990, Wiggins et al. [1] presented 8 cases in the ﬁrst report
in the English literature. In 2005, Cottin et al. [2]d e s c r i b e d
combinedpulmonaryﬁbrosisandemphysema(CPFE)based
on clinical and radiological ﬁndings and noted some char-
acteristic clinical features. Description of the pathological
mechanisms in such cases is very limited.
Deﬁned by clinical and imaging ﬁndings, CPFE is one of
clinicoradiological syndromes and probably includes several
kinds of pulmonary ﬁbrosis, so its clinical course and prog-
nosis various [3]. It is unclear how CPFE should be cate-
gorized under interstitial pneumonia to ensure the integrity
of idiopathic interstitial pneumonia (IIP) classiﬁcation. We
herein review and summarize the imaging features of CPFE.
2.Smoking and InterstitialPneumonia
Manypulmonarydiseasesarestronglyassociatedwithsmok-
ing-pulmonary emphysema, lung cancer, and some speciﬁc
interstitial diseases, such as pulmonary Langerhans cell
histiocytosis (LCH), desquamative interstitial pneumonia
(DIP), and respiratory bronchiolitis interstitial lung disease
(RBILD) [4–7].
Coexistence of pathologic ﬁndings of LCH, DIP, or
RBILD in the same patient with smoking habit has been re-
ported, and these three disease entities were sometimes cat-
egorized as smoking-related interstitial lung disease (SRILD)
in narrow deﬁnition [7, 8]. However, in a broad sense of
term, SRILD may include pulmonary emphysema, IPF, and
CPFE.
Smoking and/or dust inhalation are also important fac-
torsinthedevelopmentofidiopathicinterstitialpneumonias
[9], and most patients with idiopathic pulmonary ﬁbrosis
(IPF) have a history of smoking [10]. Overt pulmonary2 Pulmonary Medicine
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Figure 1: Diﬀuse interstitial pneumonia (nonspeciﬁc interstitial pneumonia (NSIP) pattern) with emphysema. (a) Chest X-ray shows
bibasilar ground glass and reticular opacity. Volumes of bilateral lungs are almost normal. (b) High-resolution computed tomography
(HRCT) of upper lung shows centrilobular pulmonary emphysema. (c), (d) HRCT of lower lung shows ground glass opacity along the
bronchovascular bundle including cysts with varying size. Distribution of abnormal opacity mimics NSIP.
emphysema complicates IPF in approximately 30% of
patients [11]. Iwai et al. calculated an odds ratio of 3.4
relating IPF to smoking or dust inhalation [12]. A greater
prevalence of nonspeciﬁc interstitial pneumonia (NSIP) is
alsoreportedinsmokers[13],withDIPandRBILDgenerally
conﬁned to current smokers [8, 14–16].
Smoking has been closely related to DIP, RBILD, and
LCH [8, 17] ,a n df e a t u r e so fa l lt h r e ea r er e p o r t e di np a t h -
ologic specimens of one individual [16, 17]. These 3 diseases
and IPF are also generalized as smoking-related interstitial
lung disease (SRILD) [4, 5, 18].
Based on clinical and imaging ﬁndings, Cottin et al. also
rediscussed CPFE as pulmonary emphysema, deﬁned as low-
attenuationareassurroundedbynormallungwiththinorno
wall and/or multiple bullae predominantly in upper lungs,
and interstitial pneumonia in the lower lungs with imaging
patterns of various IPs, including usual interstitial pneu-
monia (UIP), NSIP, RBILD, cryptogenic organizing pneu-
monia (OP), and others [8].
Cottin’s article reported characteristic clinical features
including poor prognosis, frequently complicated by pul-
monary hypertension [19, 20], preserved forced expiratory
volume in one second (FEV 1.0), and severely impaired dif-
fusion capacity [2, 21]. Mej´ ıa et al. also reported decreased
survival of patients with IPF and emphysema with pulmon-
ary hypertension [10]. However, we believe that the progno-
sis of interstitial pneumonia is better than that of IPF/UIP
[22], despite a high prevalence of lung cancer reported in
cases of CPFE [23, 24]a n de v e nI P F / U I P[ 25].
In a mass screening of smokers in the United States, the
COPD Gene Study Group reported interstitial shadow or
radiologically overt IP on high-resolution computed tomog-
raphy (HRCT) in approximately 8% of 2500 subjects with
chronic obstructive pulmonary disease (COPD) [26, 27].
They categorized interstitial changes on HRCT into follow-
ing four types: centrilobular, subpleural, mixed abnormal
opacity, or radiologically overt IP. On pulmonary function
tests, total lung capacity was increased in subjects withPulmonary Medicine 3
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Figure 2: Diﬀuse interstitial pneumonia (UIP pattern) with emphysema. (a) Chest X-ray shows decreased volume of bilateral lungs. Ground
glass opacity including reticular opacity and honeycomb lung in bilateral lower lungs. (b) HRCT of the right upper lobe shows paraseptal
emphysema in ventral aspect. (c) HRCT of the right lower lobe shows ground glass opacity and honeycomb lung. Traction bronchiectasis is
also observed within the areas of honeycombing.
centrilobular or mixed opacity but not in those with
subpleural abnormal opacity and overt IP. These results
suggested a correlation between interstitial lung change and
smoking.
Pulmonary injury may cause pulmonary destruction in
emphysema or abnormal repair processes in ﬁbrosis. Smok-
ing can cause simultaneous pulmonary emphysema and ﬁ-
brosis. Bates et al. [28, 29] described changes in the lung
matrix as a common pathway of destructive change and ﬁ-
brosis. However, CPFE may not be a single disease and may
include heterogeneous diseases [3].
3.Pathologic Featuresof CPFE
Pathologic features of SRILD in narrow deﬁnition (DIP,
R B I L D ,a n dL C H )h a v eb e e nd e s c r i b e d[ 7, 30–32]. Desqua-
mative interstitial pneumonia (DIP) shows accumulation of
alveolar macrophages within the alveolar lumen and mild
ﬁbroticthickeningofthealveolarsepta,butadvancedﬁbrosis
is uncommon. RBILD shows accumulation of alveolar ma-
crophages laden with brown pigment within the respira-
tory bronchioles. Langerhans cell histiocytosis results when
Langerhans histiocytes and eosinophils form granulomas in
the upper lung, cavitary nodules, and cysts by the necrosis of
granulomas.
Although CPFE is closely related to smoking, its patho-
logic features diﬀer. In noncancerous portions of lung spec-
imens obtained by lobectomy for bronchogenic carcinoma,
Kawabata et al. [33] so frequently observed relatively thick-
walled cysts that they designated the ﬁnding as air space en-
largement with ﬁbrosis (AEF). They depicted AEF related to
smoking index and possibly induced by smoking. Katzen-
stein et al. [34] found similar hyalinizing collagenous ﬁbrotic
change of the alveolar septa along the emphysematous walls
and respiratory bronchioles in the lungs of smokers; change
that they designated occult ﬁbrosis of smokers or smoking-
related interstitial ﬁbrosis.
Wright et al. [35] described 2 types of smoking-related
interstitiallungdisease-diﬀuseform,whichincludesoverlap-
ping pulmonary emphysema and IP, such as UIP or NSIP,
and localized form, which includes emphysema with ﬁbrosis,
AEF, or occult ﬁbrosis of smokers. Although pulmonary em-
physema is deﬁned as air space without ﬁbrosis, Wright
described frequently varying degrees of pulmonary ﬁbrosis
in the alveolar septa around the emphysema wall. Radiolog-
ical evaluation aids diﬀerentiation of diﬀuse and localized
forms. Fibrotic change is also identiﬁed along bronchioles
in addition to alveolar septa around pulmonary emphysema
[31].
However, pathologic features of CPFE have not been
fullystudied;thusfurtherinvestigationismandatorytoshow
pathologic characteristics of CPFE.
4.ImagingFeaturesofCPFE
Imaging features of CPFE have not been fully described. Ra-
diological ﬁndings include centrilobular and/or paraseptal
emphysema evident in the upper lungs and IP in the lower
lungs [30, 36]. On CXR, volume of lung maintains although
thereisreticularopacityinbilaterallowerlungﬁelds(Figures
1(a), 2(a),a n d7(a)). CT patterns of interstitial pneumonia
mimic those of IIP in some patients and are unclassiﬁable
in others. Cottin et al. noted that the IP pattern may mimic
NSIP (Figure 1), UIP (Figures 2 and 3), OP, RBILD, and
other such entities.
Whenpulmonaryemphysemaispresent,theradiological
pattern of interstitial pneumonia does not necessarily show
characteristic one. Akira et al. have described changes in the
radiological features of IP in the presence of pulmonary em-4 Pulmonary Medicine
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Figure 3: Diﬀuse interstitial pneumonia (UIP pattern), emphysema with ﬁbrosis. The patient underwent right lower lobectomy for lung
cancer of the right lower lobe. (a) HRCT of the right upper lobe shows severe centrilobular emphysema. (b) HRCT of the right lower
lobe shows slight ground glass opacity including several thick-walled cyst. (c) HRCT of basilar region shows subpleural ground glass
opacity and reticular opacity in the subpleural region: radiologically consistent with UIP pattern. There are some relatively thick-walled
cysts in subpleural region; however, no evidence of honeycombing. (d) Pathologic specimen (H&E staining) shows centrilobular and
paraseptal emphysema with collagen type ﬁbrosis. (e) Pathologic specimen shows dense centrilobular collagen-type ﬁbrosis, associated
with centrilobular emphysema. (f) Pathologic specimen shows cystic lesion in the acinus with destruction of alveoli and dense perilobular
and peribronchiolar ﬁbrosis. Normal alveoli adjacent to the cystic lesion. (g) Pathologic specimen shows patchy subpleural and intralobular
ﬁbrosis with alternating emphysematous, nonﬁbrotic area. Note ﬁbroblastic foci (arrows). Sharp border between advanced ﬁbrosis and
normally appeared tissue suggests UIP pattern.
physema and noted that the pattern of pathologically proven
NSIP with emphysema might mimic the pattern of UIP on
HRCT [37].
Radiological features of CPFE include large relatively
thick-walled cysts in addition to pulmonary emphysema
(Figure 4). The cysts may be related to large paraseptal
emphysema in the upper lungs just beneath the chest wall.
Some large cysts may grow within the areas with interstitial
pneumonia.Thesethick-walledcystsprobablycorrespondto
emphysema with ﬁbrosis described by Wright et al. [35]o r
air space enlargement with ﬁbrosis by Kawabata et al. [33],
butpathologicalconﬁrmationaswellasdeterminationofthe
operation of other mechanisms of cyst formation is needed.
As above mentioned, Wright et al. classiﬁed smoking-
related interstitial changes into two types: emphysema with
ﬁbrosis(localized form)andapparent interstitial pneumonia
(diﬀuse form), and HRCT seems to be useful in diﬀerential
diagnosis of the two forms [35]. However, mixture of the
two forms is sometimes observed; apparent interstitial pneu-
moniapatternwithpulmonaryemphysemamixedwithlargePulmonary Medicine 5
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Figure 4: Emphysema with ﬁbrosis, thick-walled large cyst. (a) HRCT of upper lungs shows severe centrilobular emphysema. A relatively
thick-walled cyst in the superior basal segment of the left lower lobe. Lung cancer is noted in the lingual division of the left upper lobe. (b)
HRCT of left lower lung shows large thick-walled cysts surrounded by ground glass opacity in the regions apart form pleural surface. (c)
HRCTofleftlowerlobeshowsmultiplebizarre-shapedcystsaggregatedinthecentralportionoftheleftlowerlobe.(d)Pathologicspecimens
of the resected left upper lobe shows centrilobular cystic lesion involving the membranous and respiratory bronchioles with ﬁbrosis. Note
peripheral lung parenchyma spared. (e) Mucus ﬁlling in the alveoli with slight septal thickening adjacent to the cyst (circle of Figure 5(e)).
Mucus ﬁlling and septal thickening correspond to ground glass opacity surrounding large cysts.
(a) (b)
Figure 5: Airway-centered ﬁbrosis with cysts. (a) Chest X-ray shows increased volume of bilateral lungs. (b) High-resolution computed
tomography (HRCT) of lower lung shows ground glass opacity and multiple cysts in subpleural region, but these abnormal opacities are
predominant in centrilobular region (centrilobular accentuation).6 Pulmonary Medicine
(a) (b)
(c) (d)
Figure 6: Emphysema with ﬁbrosis, pulmonary hypertension. Estimated right ventricular pressure by cardiac ultrasound is 80mmHg. (a)
Chest X-ray shows cardiomegaly with enlargement of central pulmonary arteries. (b) Contrast-enhanced CT shows dilatation of central
pulmonary arteries. There is no evidence of pulmonary thromboembolism. (c) High-resolution computed tomography (HRCT) of upper
lung shows severe pulmonary emphysema; some cystic lesions have thick wall. (d) HRCT of the lower lung shows marked destructive change
in the lung. There are several large cysts with thick wall.
thick-wall cysts is sometimes observed (Figures 1, 4,a n d6)
on HRCT images. Clinical, radiological diﬀerences between
two forms classiﬁed by Wright et al. must be investigated in
further study.
Other ﬁndings include centrilobular relatively thick-
walled cyst accompanying interstitial change or centrilobular
nodules/subpleuralcurvilinearopacity.Centrilobularlesions
correspond with airway-centered ﬁbrosis, that is, ﬁbrotic
changes along the respiratory bronchioles (Figure 5).
CPFE may show very high prevalence of lung cancer; the
possibility of lung cancer must be remained in the radio-
logicaldiﬀerentialdiagnosisofnodules/masscoincidingwith
CPFE (Figure 4).
Cottin et al. frequently observed pulmonary hyperten-
sionwithpoorprognosis,butourclinicalexperiencesuggests
less frequent pulmonary hypertension and relatively good
prognosis of interstitial pneumonia [23]. The causes of the
diﬀerence are unclear but may represent diﬀerence in race or
disease severity.
CT features of pulmonary hypertension are dilatation of
the central pulmonary arteries, enlargement of the right-
sided heart chambers, reduced number of peripheral pul-
monary artery branches, and mosaic attenuation of the lung
parenchyma [38]( Figure 6). However, changes in periph-
eral pulmonary vasculature and parenchyma are unclear
when destructive and ﬁbrotic changes in the pulmonary
parenchyma are prominent.
Acute exacerbation is less frequent for CPFE than idi-
opathic pulmonary ﬁbrosis, but its precise frequency has not
been determined (Figure 7). Neither is the precise risk of
drug-induced lung injury known. Because preexisting IP is a
risk factor for drug-induced lung injury, CPFE may aﬀect in-
dication for anticancer drug treatment [39]. In patients with
acute lung injury immediately following surgery for lungPulmonary Medicine 7
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Figure 7: Emphysema with ﬁbrosis, acute exacerbation by anticancer drug. (a)–(e) Imaging ﬁndings before acute exacerbation. (a) Chest
X-ray shows normal volume of bilateral lungs. There is reticular opacity in bilateral lower lung ﬁelds. (b), (c) High-resolution CT (HRCT).
In upper lung, centrilobular emphysema, subpleural cyst, and profuse centrilobular small nodular opacities are identiﬁed. In lower lung,
subpleural cysts and reticular opacity are noted abutting chest wall, most compatible with UIP pattern. (d)–(f) Imaging ﬁndings at acute
exacerbation. (d) Chest X-ray shows diﬀuse ground glass opacity in the left entire lung. Pneumothorax is noted on right side. (e), (f) HRCT
shows diﬀuse ground glass opacity overlapping preexisting interstitial shadow.
cancer, acute exacerbation of occult minimal IP might be
suspected because this minimal ﬁbrosis is frequently iden-
tiﬁed in postoperative patients [40].
The radiological features of CPFE correspond to patho-
logic features of destructive pulmonary changes in smokers,
such as emphysema with ﬁbrosis and overt interstitial pneu-
monia with emphysema. Further investigation is needed to
clarify clinical characteristics, complications, and prognosis
of CPFE.
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